JP2018517151A5 - - Google Patents

Download PDF

Info

Publication number
JP2018517151A5
JP2018517151A5 JP2018511342A JP2018511342A JP2018517151A5 JP 2018517151 A5 JP2018517151 A5 JP 2018517151A5 JP 2018511342 A JP2018511342 A JP 2018511342A JP 2018511342 A JP2018511342 A JP 2018511342A JP 2018517151 A5 JP2018517151 A5 JP 2018517151A5
Authority
JP
Japan
Prior art keywords
filamin
acetylglucosamine
sulfatase
subject
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018517151A (ja
JP6663000B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/032077 external-priority patent/WO2016183310A1/en
Publication of JP2018517151A publication Critical patent/JP2018517151A/ja
Publication of JP2018517151A5 publication Critical patent/JP2018517151A5/ja
Application granted granted Critical
Publication of JP6663000B2 publication Critical patent/JP6663000B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511342A 2015-05-12 2016-05-12 関節リウマチの診断のための自己抗原 Active JP6663000B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562160320P 2015-05-12 2015-05-12
US62/160,320 2015-05-12
US201562162295P 2015-05-15 2015-05-15
US62/162,295 2015-05-15
PCT/US2016/032077 WO2016183310A1 (en) 2015-05-12 2016-05-12 Autoantigens for diagnosis of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
JP2018517151A JP2018517151A (ja) 2018-06-28
JP2018517151A5 true JP2018517151A5 (enExample) 2019-06-13
JP6663000B2 JP6663000B2 (ja) 2020-03-11

Family

ID=57248470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511342A Active JP6663000B2 (ja) 2015-05-12 2016-05-12 関節リウマチの診断のための自己抗原

Country Status (6)

Country Link
US (1) US10429379B2 (enExample)
EP (1) EP3294901B1 (enExample)
JP (1) JP6663000B2 (enExample)
AU (1) AU2016261939A1 (enExample)
CA (1) CA2985637A1 (enExample)
WO (1) WO2016183310A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3463441B1 (en) 2016-06-07 2023-10-25 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis
US20180280503A1 (en) 2017-04-04 2018-10-04 The Johns Hopkins University Anti-pad2 antibody for treating and evaluating rheumatoid arthritis
JP7202010B2 (ja) * 2017-07-06 2023-01-11 国立大学法人 筑波大学 関節リウマチ診断薬
WO2020083834A1 (en) * 2018-10-22 2020-04-30 F. Hoffmann-La Roche Ag Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1105734B (it) * 1977-07-14 1985-11-04 Syva Co Prova di legame di competizione di antienzima omogeneo
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US5248595A (en) 1991-10-08 1993-09-28 Eastman Kodak Company Wash composition, test kit and method for determination of microorganisms associated with periodontal diseases
US5750356A (en) 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
AU2002230997A1 (en) 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
WO2003029277A2 (en) * 2001-10-03 2003-04-10 Rigel Pharmaceuticals, Inc. Modulators of lymphocyte activation and migration
US8198401B2 (en) * 2003-03-07 2012-06-12 London Health Sciences Centre Research Inc. Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
EP1664796B1 (en) 2003-09-15 2010-12-15 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate ankylosing spondylitis
PT1882946E (pt) 2003-12-23 2010-04-21 Roche Diagnostics Gmbh Método para avaliar artrite reumatóide através da medição de anti-ccp e interleucina 6
EP1721162B1 (en) 2004-02-27 2008-09-24 Roche Diagnostics GmbH Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a
EP1774328A1 (en) 2004-07-23 2007-04-18 Novartis AG Biomarkers for rheumatoid arthritis (ra)
US20070148704A1 (en) 2005-10-06 2007-06-28 Ursula Klause Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
CN102597268B (zh) * 2009-09-03 2017-09-22 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控类风湿性关节炎的方法
WO2012040264A2 (en) * 2010-09-21 2012-03-29 The General Hospital Corporation Diagnostic tests for immune reactivity with human endothelial cell growth factor
ES2574790T3 (es) * 2011-07-01 2016-06-22 Inova Diagnostics, Inc. Procedimiento para aumentar la especificidad de pruebas de diagnóstico para enfermedades autoinmunitarias
CA3261641A1 (en) 2013-03-13 2025-06-12 Oncour Pharma, Inc. Immune-modifying particles for the treatment of inflammation
EP3463441B1 (en) * 2016-06-07 2023-10-25 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis

Similar Documents

Publication Publication Date Title
Cavazzana et al. Systemic sclerosis-specific antibodies: novel and classical biomarkers
Mahler et al. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights
Poole et al. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments
He et al. Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer
Szarka et al. Recognition of new citrulline‐containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients
JP2018517151A5 (enExample)
CN102326080A (zh) A+生物标志物的试验
WO2009115612A1 (en) Biomarkers for rheumatoid arthritis
AU2016353453A1 (en) Methods and compositions for assessing antibody specificities
JP2017532544A5 (enExample)
Rytkönen-Nissinen et al. IgE reactivity of the dog lipocalin allergen Can f 4 and the development of a sandwich ELISA for its quantification
RU2017114626A (ru) Антитело, связывающее линейный эпитоп человеческого р53, и его применение в диагностике
AU2006246342B2 (en) Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/ diagnostic use
AU2012257781A1 (en) Method for the diagnosis of early Rheumatoid Arthritis
CN104086640A (zh) 一种检测肿瘤免疫标志物birc5自身抗体氨基酸序列及应用
CN116239684B (zh) 针对人钙网蛋白的兔单克隆抗体及其制备方法和应用
JP5712513B2 (ja) ヒトサイトメガロウイルス感染の検出方法
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法
Wang et al. Keratin 8 is a novel autoantigen of rheumatoid arthritis
AU2016261939A1 (en) Autoantigens for diagnosis of rheumatoid arthritis
Mahler et al. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Nicholson et al. PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20
RU2013158627A (ru) Антитела к рецептору человеческого эритропоэтина и способы их применения
JP2014162772A (ja) 抗シトルリン化タンパクヒトIgG抗体およびその用途
Konieczna et al. Novel tool in rheumatoid arthritis diagnosis—The usage of urease flap region peptidomimetics